ACRS - Aclaris Therapeutics EPS misses by $0.65 misses on revenue November, 07 2019 04:05 PM Aclaris Therapeutics Inc. Aclaris Therapeutics (NASDAQ:ACRS): Q3 GAAP EPS of -$1.34 misses by $0.65.More news on: Aclaris Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...